Overview
The rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indications as part of standard of care and have well-defined safety profiles.
Eligibility
Inclusion Criteria:
- ≥18 years old
- Ability to provide signed informed consent form.
- Male or non-pregnant female patient (Pregnancy status to be confirmed verbally from the female patient of reproductive age)
- Presentation with acute coronary syndrome or chronic coronary syndrome with stable angina or angina equivalent symptoms or with a positive noninvasive test for ischemia or evidence of a functionally significant coronary stenosis.
- Patient having social security number.
- Patient treated only with Vivo ISAR stent in case of single or multiple vessel stenting
Exclusion Criteria:
- Concurrent participation in another clinical trial.
- Having benefited from an angioplasty of ≤ 1 month with a stent other than Vivo ISAR.
- Planned elective surgery in next 6 months
- Cardiogenic shock/ hemodynamically unstable patients
- Concurrent medical condition with a life expectancy of less than 12 months
- History of cerebrovascular accident in the last 6 months.
- Vulnerable patient under guardianship or curatorship